Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study

Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a... AbstractTo determine the role of hepatitis C virus (HCV) infection in the aetiology of hepatocellular carcinoma (HCC) in Zimbabwe, HCV antibodies (anti-HCV) were determined in sera from 63 HCC patients using a second generation enzyme immunoassay. Anti-HCV was found in 15 patients (23·8%), 12 of whom (80%) were males. The mean ages of anti-HCV positive and anti-HCV negative patients were 62·1 (sd = 10·6) and 44·3 (sd = 15·2) years, respectively (P < 0·001). HIV antibodies were found in patients (28·8%), 12 of whom (70·6%) were males. The mean ages of HIV positive and HIV negative patients were 39·4 (sd = 15·7) and 51·0 (sd = 15·2) years (P = 0·011). Hepatitis B surface antigen (HBsAg) was detected in patients (42·6%) with mean ages of HBsAg positive vs negative patients of 41·5 (sd = 15·4) years for HIV positive and 53·1 (sd = 15·1) years for HIV negative subjects (P = 0·005).Younger HCC patients had high prevalences of HBsAg and anti-HIV and a low prevalence of anti-HCV; while older patients had a high prevalence of anti-HCV and low prevalences of HBsAg and anti-HIV. This study suggested that HCV infection is probably an important aetiological agent of HCC in Zimbabwe; however, the role of HIV infection as a cause of HCC either singly or as a co-factor with hepatitis B virus infection remains speculative and warrants further study. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Transactions of The Royal Society of Tropical Medicine and Hygiene Oxford University Press

Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study

Loading next page...
 
/lp/oxford-university-press/hepatitis-c-virus-and-hiv-antibodies-in-patients-with-hepatocellular-dM6EEDxMbG

References (15)

Publisher
Oxford University Press
Copyright
© Published by Oxford University Press.
ISSN
0035-9203
eISSN
1878-3503
DOI
10.1016/S0035-9203(97)90029-8
Publisher site
See Article on Publisher Site

Abstract

AbstractTo determine the role of hepatitis C virus (HCV) infection in the aetiology of hepatocellular carcinoma (HCC) in Zimbabwe, HCV antibodies (anti-HCV) were determined in sera from 63 HCC patients using a second generation enzyme immunoassay. Anti-HCV was found in 15 patients (23·8%), 12 of whom (80%) were males. The mean ages of anti-HCV positive and anti-HCV negative patients were 62·1 (sd = 10·6) and 44·3 (sd = 15·2) years, respectively (P < 0·001). HIV antibodies were found in patients (28·8%), 12 of whom (70·6%) were males. The mean ages of HIV positive and HIV negative patients were 39·4 (sd = 15·7) and 51·0 (sd = 15·2) years (P = 0·011). Hepatitis B surface antigen (HBsAg) was detected in patients (42·6%) with mean ages of HBsAg positive vs negative patients of 41·5 (sd = 15·4) years for HIV positive and 53·1 (sd = 15·1) years for HIV negative subjects (P = 0·005).Younger HCC patients had high prevalences of HBsAg and anti-HIV and a low prevalence of anti-HCV; while older patients had a high prevalence of anti-HCV and low prevalences of HBsAg and anti-HIV. This study suggested that HCV infection is probably an important aetiological agent of HCC in Zimbabwe; however, the role of HIV infection as a cause of HCC either singly or as a co-factor with hepatitis B virus infection remains speculative and warrants further study.

Journal

Transactions of The Royal Society of Tropical Medicine and HygieneOxford University Press

Published: Oct 1, 1997

There are no references for this article.